Efficacy and safety of delgocitinib in treating chronic hand eczema: A systematic review and meta-analysis of randomized controlled trials
Background: Chronic hand eczema (CHE) is a persistent inflammatory skin condition that is often difficult to manage and associated with substantial functional impairment and reduced quality of life. Delgocitinib, a topical pan-Janus kinase inhibitor, has emerged as a potential nonsteroidal therapeut...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2025-12-01
|
| Edice: | Proceedings of Singapore Healthcare |
| On-line přístup: | https://doi.org/10.1177/20101058251409425 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|